Loading...

Collegium Pharmaceutical, Inc.

COLL•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$32.50
$0.22(0.68%)
U.S. Market opens in NaNh NaNm

Collegium Pharmaceutical, Inc. (COLL) Stock Overview

Explore Collegium Pharmaceutical, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1B
P/E Ratio16.23
EPS (TTM)$1.73
ROE0.24%
Fundamental Analysis

AI Price Forecasts

1 Month$39.99
3 Months$48.25
1 Year Target$47.35

COLL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Collegium Pharmaceutical, Inc. (COLL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 37.69, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $47.35.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 16.23 and a market capitalization of 1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.68%
5-Day Change
-3.50%
1-Month Change
-2.20%
3-Month Change
-28.57%
6-Month Change
-7.93%
Year-to-Date (YTD) Change
-29.81%
1-Year Change
21.36%
3-Year Change
38.89%
5-Year Change
39.78%
All-Time (Max) Change
164.44%

Contact Information

https://www.collegiumpharma.com
781 713 3699
100 Technology Center Drive, Stoughton, MA, 02072

Company Facts

357 Employees
IPO DateMay 7, 2015
CountryUS
Actively Trading

Frequently Asked Questions